Chronic Illnesses: Genetic Engineering

(asked on 1st March 2021) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of future routes to market for gene therapies with regard to the potential transformative effect of those one-off therapeutics for the treatment of chronic disease.


Answered by
Jo Churchill Portrait
Jo Churchill
Minister of State (Department for Work and Pensions)
This question was answered on 9th March 2021

NHS England and NHS Improvement published the ‘NHS commercial framework for new medicines’ on 23 February 2021. The framework sets out the routes to commissioning for medicines and states that the main route for commissioning medicines, which includes gene and cell therapies, is expected to be through a National Institute for Health and Care Excellence (NICE) appraisal. The framework also sets out the commercial options that may be available to companies that NHS England and NHS Improvement and NICE may pursue in particular circumstances.

Reticulating Splines